Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 211 Neoplasm Metastasis 15 Neoplasms 14 Carcinoma, Intraductal, Noninfiltrating 9 Advanced Breast Cancer 7 Breast Neoplasms, Male 6 Breast Diseases 6 Breast Carcinoma In Situ 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Arthralgia 4 Neoplasms by Site 3 Breast Cancer Metastatic 3 Recurrence 2 Osteoporosis 2 Obesity 2 Multiple Endocrine Neoplasia Type 1 2 Carcinoma, Non-Small-Cell Lung 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Patient Compliance 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Cetuximab 16 Specimen Handling 15 Nivolumab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 Sorafenib 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 osimertinib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡